Nocturnal Bruxism Clinical Trial
Official title:
Botulinum Toxin A Injectable Solution in the Management of Bruxism
A Clinical Trial Study to investigate the potential performance of BTXA on masseter muscle on patient with nocturnal bruxism and to check the pain scale and share this clinical experience.
Experimental group we will use BTX-A administration group. All patients (Male/Female) with bruxism associated with chronic pain in masseter muscles bilaterally participated in this study. The patients age 18-60 years. According to the diagnostic grading system of bruxism all subjects will have an assessment including a bruxism questionnaire (i.e., oral history taking with specific focus on bruxism habits) plus a clinical examination to evaluate bruxism signs and symptoms. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02870543 -
Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism
|
Phase 3 | |
| Completed |
NCT05620316 -
The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism
|
N/A | |
| Recruiting |
NCT06259786 -
Investigation of Adolescents With Nocturnal Bruxism
|